• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchInhibitor Therapeutics
    Picture of Inhibitor Therapeutics logo

    INTI — Inhibitor Therapeutics Share News

    $0.070.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      $12.25m
    • Enterprise Value
      $11.74m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • INTI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    INTI Dividends
    • Brief: Inhibitor Therapeutics Receives Prostate Cancer IND Clearance From FDA

      22/01/2020 13:11
    • Brief: Hedgepath Pharmaceuticals Provides Corporate Update For The Fourth Quarter And Year End 2018

      07/03/2019 14:43
    • Brief: Hedgepath Pharmaceuticals, Mayne Pharma Enter Updated Collaboration & Funding Agreements

      17/12/2018 22:11
    • Brief: HedgePath says FDA grants orphan drug designation to its pill

      02/06/2016 14:00

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.